These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38922986)

  • 1. Identifying radiogenomic associations of breast cancer based on DCE-MRI by using Siamese Neural Network with manufacturer bias normalization.
    Chen J; Zeng H; Cheng Y; Yang B
    Med Phys; 2024 Oct; 51(10):7269-7281. PubMed ID: 38922986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
    Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
    Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convolutional Neural Network Using a Breast MRI Tumor Dataset Can Predict Oncotype Dx Recurrence Score.
    Ha R; Chang P; Mutasa S; Karcich J; Goodman S; Blum E; Kalinsky K; Liu MZ; Jambawalikar S
    J Magn Reson Imaging; 2019 Feb; 49(2):518-524. PubMed ID: 30129697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning models for differential diagnosing HER2-low breast cancer: A radiomics approach.
    Chen X; Li M; Su D
    Medicine (Baltimore); 2024 Aug; 103(33):e39343. PubMed ID: 39151526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
    Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
    Eur Radiol; 2024 Sep; 34(9):6132-6144. PubMed ID: 38363315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
    Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes.
    Ba ZC; Zhang HX; Liu AY; Zhou XX; Liu L; Wang XY; Nanding A; Sang XQ; Kuai ZX
    Clin Breast Cancer; 2024 Jul; 24(5):e417-e427. PubMed ID: 38555225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
    Zhang X; Teng X; Zhang J; Lai Q; Cai J
    Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Task-based assessment of a convolutional neural network for segmenting breast lesions for radiomic analysis.
    Spuhler KD; Ding J; Liu C; Sun J; Serrano-Sosa M; Moriarty M; Huang C
    Magn Reson Med; 2019 Aug; 82(2):786-795. PubMed ID: 30957936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesion attention guided neural network for contrast-enhanced mammography-based biomarker status prediction in breast cancer.
    Qian N; Jiang W; Wu X; Zhang N; Yu H; Guo Y
    Comput Methods Programs Biomed; 2024 Jun; 250():108194. PubMed ID: 38678959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of human epidermal growth factor receptor 2 (HER2) status in breast cancer by mammographic radiomics features and clinical characteristics: a multicenter study.
    Deng Y; Lu Y; Li X; Zhu Y; Zhao Y; Ruan Z; Mei N; Yin B; Liu L
    Eur Radiol; 2024 Aug; 34(8):5464-5476. PubMed ID: 38276982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
    Sang L; Liu Z; Huang C; Xu J; Wang H
    Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions.
    Cui H; Sun Y; Zhao D; Zhang X; Kong H; Hu N; Wang P; Zuo X; Fan W; Yao Y; Fu B; Tian J; Wu M; Gao Y; Ning S; Zhang L
    J Transl Med; 2023 Jan; 21(1):44. PubMed ID: 36694240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
    Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
    J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics Analysis Based on Automatic Image Segmentation of DCE-MRI for Predicting Triple-Negative and Nontriple-Negative Breast Cancer.
    Ma M; Gan L; Jiang Y; Qin N; Li C; Zhang Y; Wang X
    Comput Math Methods Med; 2021; 2021():2140465. PubMed ID: 34422088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
    Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
    J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.
    Fan M; Li H; Wang S; Zheng B; Zhang J; Li L
    PLoS One; 2017; 12(2):e0171683. PubMed ID: 28166261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of MRI Radiomics Models in Evaluating the Low HER2 Expression in Breast Cancer.
    Li H; Hou Y; Xue LY; Fan WL; Gao BL; Yin XP
    Curr Med Imaging; 2024; 20():e15734056234429. PubMed ID: 38726785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.